Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma

NCT00017693 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT00017693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00017693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2
Overall status
Completed
Start date
May 31, 1998
Completion date
February 29, 2000
Enrollment
62 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma